Skip to main content
Earnings Labs
Aligos Therapeutics, Inc. logo

Aligos Therapeutics, Inc. (ALGS)

NASDAQ·Healthcare·Biotechnology

$5.34

+6.91%

Mkt Cap $43.23M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (4 analysts)

$20.00

Range $20.00$20.00

Implied Upside

+274.9%

Consensus $20.00 vs current $5.34